This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Yumi Ogawa: Innovator in Pharmaceutical Composition
Introduction
Yumi Ogawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceutical compositions, particularly in enhancing the solubility of complex compounds. With a total of 2 patents to her name, Ogawa continues to push the boundaries of innovation in her industry.
Latest Patents
Ogawa's latest patents focus on the preparation of tetracyclic compounds at high doses. One of her notable inventions involves an improved solubility of a pharmaceutical composition containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile. This is achieved by forming granules of the compound or its salt and allowing these granules to be present with a disintegrating agent. This innovative approach enhances the effectiveness of the pharmaceutical formulation.
Career Highlights
Yumi Ogawa is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to collaborate with other talented professionals in the field, further advancing her research and development efforts.
Collaborations
Ogawa has worked alongside notable colleagues such as Kensuke Okazaki and Takahiro Yamamura. Their collaborative efforts have contributed to the success of various projects and innovations within the company.
Conclusion
Yumi Ogawa is a trailblazer in the pharmaceutical industry, with her innovative patents and collaborative spirit driving advancements in drug formulation. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
